Marta H Branquinha Selected Research

calpain inhibitors

2/2022	Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B.
1/2014	The calpain inhibitor MDL28170 induces the expression of apoptotic markers in Leishmania amazonensis promastigotes.
7/2010	Effects of the calpain inhibitor MDL28170 on the clinically relevant forms of Trypanosoma cruzi in vitro.
8/2006	Antileishmanial activity of MDL 28170, a potent calpain inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marta H Branquinha Research Topics

Disease

12	Infections 05/2021 - 01/2009
6	Chagas Disease (American Trypanosomiasis) 01/2021 - 06/2012
4	Leishmaniasis 02/2022 - 02/2013
3	Blister (Bulla) 12/2019 - 01/2006
3	Coinfection 01/2019 - 01/2014
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 01/2014
2	Opportunistic Infections (Opportunistic Infection) 07/2021 - 01/2017
2	Parasitic Diseases (Parasitic Disease) 10/2016 - 08/2006
1	Visceral Leishmaniasis (Kala Azar) 10/2021
1	Cutaneous Leishmaniasis 10/2021
1	Cystic Fibrosis (Mucoviscidosis) 01/2021
1	Candidiasis (Moniliasis) 01/2020
1	Mycoses (Diseases, Fungus) 11/2019
1	Wounds and Injuries (Trauma) 08/2018
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 08/2018
1	Cutaneous Candidiasis 02/2017

Drug/Important Bio-Agent (IBA)

8	Protease Inhibitors (Protease Inhibitor)IBA 07/2021 - 01/2009
7	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 08/2006
4	calpain inhibitorsIBA 02/2022 - 08/2006
4	Lopinavir FDA Link 05/2021 - 12/2016
3	calpain inhibitor IIIIBA 02/2022 - 07/2010
2	Polystyrenes (Polystyrene)IBA 05/2021 - 11/2019
2	AcetylglucosamineIBA 05/2021 - 11/2019
2	Mannose (D-Mannose)IBA 05/2021 - 11/2019
2	LipidsIBA 05/2021 - 11/2019
2	GlycoconjugatesIBA 05/2021 - 11/2019
2	EsterasesIBA 05/2021 - 02/2017
2	EnzymesIBA 05/2021 - 01/2020
2	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 11/2014
2	benzonidazole (benznidazole)IBA 01/2019 - 11/2018
2	Pharmaceutical PreparationsIBA 11/2018 - 07/2010
2	Nelfinavir (Viracept)FDA Link 08/2018 - 12/2016
1	Drug CombinationsIBA 02/2022
1	isopentyl caffeateIBA 10/2021
1	VaccinesIBA 09/2021
1	Ergosterol (Lumisterol)IBA 05/2021
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 05/2021
1	AzolesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	cruzipainIBA 01/2021
1	CopperIBA 01/2020
1	SilverIBA 01/2020
1	ManganeseIBA 01/2020
1	PeptidomimeticsIBA 12/2019
1	Glucose (Dextrose)FDA LinkGeneric 11/2019
1	ChitinIBA 11/2019
1	Peptides (Polypeptides)IBA 11/2019
1	Serine (L-Serine)FDA Link 11/2019
1	Tosylphenylalanyl Chloromethyl Ketone (TPCK)IBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	miltefosine (Impavido)IBA 01/2019
1	NifurtimoxIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 08/2018
1	Oxidoreductases (Dehydrogenase)IBA 08/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2016
1	Leucyl Aminopeptidase (Peptidase S)IBA 10/2016
1	1,10-phenanthroline-5,6-dioneIBA 01/2016
1	1,10-phenanthrolineIBA 01/2016
1	ChromatinIBA 01/2014
1	pepstatin (pepstatin A)IBA 06/2012
1	leupeptinIBA 01/2006
1	AntipainIBA 01/2006

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 02/2022 - 01/2014
2	Therapeutics 01/2019 - 08/2018
1	Disarticulation 01/2021